Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

TerminatedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Rheumatoid Arthritis (RA)
Interventions
OTHER

non-interventional study

Study with 4 arms/groups with 36 patients per group. In total 144 patients.

OTHER

non-interventional study

Study with 4 arms/groups with 36 patients per group. In total 144 patients.

OTHER

non-interventional study

Study with 4 arms/groups with 36 patients per group. In total 144 patients.

OTHER

non-interventional study

Study with 4 arms/groups with 36 patients per group. In total 144 patients.

Trial Locations (13)

2000

Frederiksberg Hospital / Reumatologisk Afdeling, Frederiksberg

2900

Gentofte Hospital, Medicinsk afd. C, Hellerup

3400

Hillerod Hospital/Reumatologisk Afdeling, Hillerød

4300

Holbaek Sygehus, Holbæk

5000

Odense Universitets Hospital/Reumatologisk Afdeling C, Odense C

5700

Svendborg Sygehus / Medicinsk Afdeling M, Svendborg

6000

Reumatologisk afd, Kolding

6700

Sydvestjysk Sygehus / Reumatologisk Afdeling, Esbjerg

7100

Vejle Sygehus / Medicinsk Afdeling, Vejle

8000

Aarhus Universitetshospital/Reumatologisk Afdelning U, Aarhus C

8800

Hospitalsenheden Viborg Reumatologisk Ambulatorium, Viborg

8930

Regionshospitalet Randers / Reumatologisk Klinik, Randers NØ

9000

Aalborg Universitetshospital Nord/Reumatologisk Afdelning, Aalborg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01691014 - Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents | Biotech Hunter | Biotech Hunter